On December 15, 2024, the much-anticipated “SO Health 2024 Nutrition and Health Food Innovation TOP100 List Release Conference” was held in grand style. Mr. Yang Weijun, General Manager of Wuhan Jianbao Biotechnology Co., Ltd., was invited to attend the event and accept an award on-site.
The honored product was Wuhan Jianbao Biotech’s flagship offering—Yak Bone Small Molecule Oligopeptide. This product stood out for its exceptional innovation, rich nutritional value, and broad market impact. After a thorough review by a panel of experts, it earned its place on the “SO Health 2024 Nutrition and Health Food Innovation TOP100 List.” This recognition not only affirms the outstanding quality of Jianbao Biotech’s Yak Bone Small Molecule Oligopeptide but also highlights the company’s commitment to innovation-driven development and product excellence. Furthermore, it serves as a testament to the company’s robust R&D and production capabilities.
In the designated showcase area for listed products, Wuhan Jianbao Biotech’s Yak Bone Small Molecule Oligopeptide took center stage. As a specialized dietary product, it boasts three technological patents. Under the guidance of Professor Li Yong from Peking University Health Science Center, the product has undergone continuous optimization and upgrades, earning a stellar reputation in the market. The display board at the exhibition featured expert comments: “This product is a small-molecule oligopeptide derived from yak bone oligopeptide powder and yak bone marrow peptide powder. It is characterized by its low molecular weight, high absorption efficiency, and protein content of up to 92%, making it a valuable addition to healthy living.”
The selection process for the “SO Health Nutrition and Health Food Innovation TOP100 List” was highly competitive, with hundreds of companies submitting applications. Following a rigorous preliminary review, over 100 products advanced to the expert evaluation stage. A panel of 30 industry authorities conducted live evaluations, including tasting and thorough assessment, ensuring an objective, fair, and transparent selection process. Wuhan Jianbao Biotech’s Yak Bone Small Molecule Oligopeptide excelled during this process, securing its place on the list. The product was officially announced and awarded at the conference.
Looking ahead, Wuhan Jianbao Biotechnology Co., Ltd. will continue to uphold its core values of “integrity as the foundation, innovation as the driver, and quality as life.” The company remains dedicated to launching more high-quality and health-focused nutritional products, contributing to healthier lifestyles for consumers. Additionally, it will actively participate in industry exchanges and collaborations, fostering the sustainable development of China’s nutrition and health industry.